PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
Therapeutic applications of PARP inhibitors in ovarian cancer - ScienceDirect
藥學雜誌電子報145期
Mechanism of action of PARP (poly-ADP-ribose-polymerase). Single strand... | Download Scientific Diagram
BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression | Scientific Reports
PARP Inhibition: A New Approach To Cancer Therapy? Dr. Geert Kolvenbag - ppt download
Lynparza recommended for approval in ovarian cancer | Cambridge Network
A decade of clinical development of PARP inhibitors in perspective - Annals of Oncology
PARP inhibitors in cancer treatment | OncologyPRO
Frontiers | Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors | Oncology
Dual mechanism of action of PARPi. Notes: Olaparib inhibits parylation... | Download Scientific Diagram
Olaparib - Wikipedia
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance | Experimental & Molecular Medicine
PARP inhibitor resistance: the underlying mechanisms and clinical implications | Molecular Cancer | Full Text
FDA Approves Olaparib, Rucaparib to Treat Prostate Cancer - National Cancer Institute
PARP Inhibitors: Where Are We in 2020 and What's Coming Next?
Olaparib
Mechanism of sensitivity to PARP inhibition in BRCA-deficient cells SSB | Download Scientific Diagram
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
Olaparib mechanism, specifically in BRCA-deficient cells compared to... | Download Scientific Diagram
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
PARP inhibitors in ovarian cancer - ScienceDirect
